Cannabinoids to Treat Acute Pain: Study

New study showed a small but significant decline in subjective pain scores for cannabinoid treatment, but no increase in serious adverse events suggested the safety of using cannabinoids to treat acute pain.

There is low-quality evidence indicating that cannabinoids may be a safe alternative for a small but significant decline in subjective pain score when treating acute pain, reports a new study. The findings of the study are published in the journal Cannabis and Cannabinoid Research.

The article entitled "Cannabinoids in the Management of Acute Pain: A Systematic Review and Meta-analysis" was coauthored by Herman Johal, MD, MPH, Ph.D., McMaster University, Hamilton, Canada and colleagues from McMaster University and Northern Ontario School of Medicine, Thunder Bay.

Cannabis
Cannabis has a long history of medicinal, recreational, and industrial use and comes from a bushy plant with thick sticky flowers called Cannabis Sativa

‘The usefulness of cannabis-derived medicines in the treatment of pain, both acute and chronic, is still vigorously debated.’
Read More..

The researchers included six trials in their study, five using oral cannabinoids, and one using intramuscular cannabinoids. They reported a significant difference in effect size between the oral and nonoral routes of administration, with intramuscular cannabinoids yielding a significant reduction in pain relative to placebo. There was no difference in effect between oral cannabinoids and placebo.

Editor-in-Chief Daniele Piomelli, Ph.D. University of California-Irvine, School of Medicine, states: "The meta-analysis conducted in this study reinforces the need for more rigorous studies to assess whether cannabis might be effective in the treatment of acute pain conditions."

Source-Eurekalert

Endocannabinoids Could Modulate Various Mood Disorders
Endogenous cannabinoid system (ECS), especially CB1-mediated endocannabinoid signaling has shown promising results in treatment of mood disorders in animal studies.

Elder COPD Patients Likely to Use Synthetic Oral Cannabinoids
Researchers suggest that greater frequency of cannabinoid use, and use in potentially concerning ways, raise possible safety concerns in Chronic obstructive pulmonary disease (COPD) elderly patients.

Think Twice Before Using Synthetic Cannabinoids
Marijuana poses dangerous health effects and with the increased spread of synthetic cannabinoids in the public can lead to adverse health effects.